Gregory T. Hradsky's Net Worth

$5.62 Thousand

Estimate Recalculated Feb 7, 2024 03:45PM EST

Who is Gregory T. Hradsky?

Gregory T. Hradsky does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cyclacel Pharmaceuticals, Inc., and SIELOX INC.

SEC CIK

Gregory T. Hradsky's CIK is 0001439092

Past Insider Trading and Trends

2021 was Gregory T. Hradsky's most active year for acquiring shares with 2 total transactions. Gregory T. Hradsky's most active month to acquire stocks was the month of April. 2008 saw Gregory T. Hradsky paying a total of $0.00 for 50,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cyclacel Pharmaceuticals, Inc. (CYCC) Snapshot price: $2.3674

Investor

Gregory T. Hradsky owns 2,374 units of Common Stock which is worth $5,620.21. From 2011 to 2021 Gregory T. Hradsky acquired a total of 2,374 shares in Cyclacel Pharmaceuticals, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.37K
—
—
2.37K
Jun 15
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 23
Form 3
—
0
—
—
0
No matching records found

SIELOX INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 30
Form 3
—
0
—
—
0
No matching records found